THERAPEUTIC PRODUCT EFFECT INCREASED

This adverse event was reported 1165 times

THERAPEUTIC PRODUCT EFFECT INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Amino Acid Hypertonic Solution [EPC] 1 0.0063
1 Melatonin Receptor Agonist [EPC] 15 0.0011
2 Oxytocic [EPC] 3 0.0010
3 alpha-1 Adrenergic Agonist [EPC] 4 0.0009
4 Orexin Receptor Antagonist [EPC] 12 0.0006
5 Anti-coagulant [EPC] 2 0.0005
6 Non-Standardized Fungal Allergenic Extract [EPC] 1 0.0005
7 Anticholinergic [EPC] 6 0.0004
8 mu-Opioid Receptor Agonist [EPC] 1 0.0003
9 Progesterone [EPC] 7 0.0003
See all drug classes enriched for association with THERAPEUTIC PRODUCT EFFECT INCREASED